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Abstract
To identify quantitative trait loci (QTLs) responsible for regulating plasma lipid concentration associated with obesity,
linkage analysis was carried out on the 190 F2 progeny of a cross between C57BL/6J female and KK-Ay (Ay allele at the
agouti locus congenic) male. In F2 a/a (agouti locus genotype) mice, two QTLs were identified on chromosome 1 and a QTL
on chromosome 3 for total-cholesterol. A QTL for HDL-cholesterol was identified on chromosome 1 and a QTL for NEFA
on chromosome 9. In F2 Ay/a mice, two QTLs for HDL-cholesterol were found on chromosome 1. Loci for other lipids with
suggestive linkage were also identified. In both F2 mice, one QTL on chromosome 1 for total- and HDL-cholesterol was
mapped near D1Mit150, in the vicinity of the apolipoprotein A-II (Apoa2) locus. Seven nucleotide substitutions out of 309
nucleotide apolipoprotein A-II cDNA sequences were identified between KK and C57BL/6J. The Ay allele may be an
indication of the plasma lipid levels, but its influence was less apparent than in the case of weight control. The loci for lipids
were not on identical chromosomes with those previously identified for obesity, suggesting that hyperlipidemia in KK does
not coincidentally occur with obesity. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The prevalence of obesity is a common health
problem in modern nations, not only because of
morbidity, but also because an obese state may be
a serious risk factor for complications such as non-
insulin-dependent diabetes mellitus (NIDDM), alter-
ations in plasma lipid metabolism and atherosclerosis
leading to coronary heart diseases [1]. These compli-
cations are considered to be in£uenced by genetic
and non-genetic factors [2]. The primary pathogene-
sis triggering complications is uncertain, although
causal relations between obesity and other complica-
tions have been described. Patients with diabetes
mellitus tend to have elevated peripheral lipid levels
and generally show increased mortality [3].
KK mice develop NIDDM with moderate obesity
at relatively late onset [4]. NIDDM in KK mice is
primarily characterized by the impairment of glucose
tolerance as well as insulin resistance with basal hy-
perinsulinemia [5]. These features are exacerbated in
KK-Ay mice, a congenic strain in which the Ay allele
at the agouti locus is introduced onto a KK back-
ground by repetitive backcrossing of more than
10 generations, with consequent overt diabetes and
massive obesity [6,7]. The concentrations of plasma
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lipids, such as triglyceride, total- and high density
lipoproteins (HDL)-cholesterol, non-esteri¢ed fatty
acids (NEFA) and phospholipid in KK are elevated
compared to the lean and normoglycemic C57BL/6J
strain. Since plasma lipoproteins and cholesterol lev-
el are based on multigenic regulation with certain
heterogeneity [8,9], the authors carried out linkage
analysis to identify quantitative trait loci that regu-
late various elevated plasma lipids in KK using the
F2 intercross progeny produced from a genetic cross
between C57BL/6J female and KK-Ay male.
Regarding body weight control, obesity in KK is
controlled by multiple genes and introduction of the
Ay allele leads to massive obesity by inducing di¡er-
ent combinations of responsible loci for the traits
[10]. The introduction of the Ay allele in KK (KK-
Ay) causes further increase in lipid levels. Thus, study
was made to determine whether putative genetic loci
for plasma lipid coincidentally occur with those for
body weight and whether the Ay allele a¡ects the
quantitative regulation of plasma lipid concentration
in the same way as seen in body weight control.
2. Materials and methods
2.1. Mice and genetic cross
All mice in this study were inbred strains and pur-
chased from Clea Japan (Tokyo, Japan). Three
C57BL/6J (coat color locus allele, aa; BB; CC) fe-
male mice were mated with a KK-Ay (Aya; BB; Cc)
male to produce F1 mice. KK-Ay is a congenic
strain, in which the Ay allele at the agouti locus
(initially from C57BL/6J-Ay) has been transferred
to the inbred KK strain background by repetitive
backcrossing. F2 populations were obtained by inter-
crossing F1 mice with the Ay/a genotype. (Ay/a mice
could be easily recognized by the yellow pigmenta-
tion of coat color and the homozygote for Ay is
lethal at the time of implantation [11]). Pregnant F1
females were raised separately and, on the day they
gave birth, dams only with litters containing ¢ve to
nine pups were chosen to wean F2 mice. F2 mice
were weaned at 21 days after birth and each was
housed in a Plexiglas cage throughout the study.
From more than 200 F2 progenies, 190 mice were
randomly selected so as to minimize age di¡erences
in the experiments. The 190 F2 mice were comprised
of 93 mice (49 male and 44 female) with the a/a
genotype (black coat color) and 97 mice (49 male
and 48 female) with the Ay/a genotype (yellow). Al-
bino F2 mice were discarded, since the presence of
the Ay allele could not be con¢rmed. All mice were
maintained in a temperature-controlled (22 þ 3‡C)
room, speci¢c pathogen free, with a regular light
cycle of 12:12 h light/dark, and relative humidity
of 50%. Diet (rodent pellet chow, CE-2 (342.2 kcal/
100 g, containing 4.4% crude fat), Clea Japan) and
tap water were available ad libitum.
2.2. Plasma lipid measurement
Plasma concentrations of triglyceride, total- and
HDL-cholesterol, NEFA, and phospholipid were de-
termined. At autopsy, after 24 h fasting, blood was
drawn from the heart into heparinized microtubes.
To separate the plasma from whole blood, the tubes
were centrifuged at 7000 rpm for 5 min at 4‡C im-
mediately after drawing. All samples were placed at
380‡C until use. Plasma lipid was determined enzy-
matically with an autoanalyzer (Hitachi 7050, Hita-
chi, Japan) using clinical chemical kits (Wako, Ja-
pan). HDL-cholesterol was measured in plasma
from which low density lipoprotein (LDL)+very
low density lipoprotein (VLDL) fractions had been
previously precipitated with phosphotungstic acid
and magnesium chloride according to the instruc-
tions of the manufacturer.
Plasma was obtained from mouse at 195^198 days
after birth for a/a males, 206^207 days for a/a fe-
males, 184^186 days for Ay/a males and 191^192
days for Ay/a females.
2.3. Genotyping
A table of microsatellite markers used in the
present study with the chromosomal location from
the information from the mouse genome data base
(December 8, 1997) will be provided upon request to
the authors. Ninety-seven microsatellite marker loci
were genotyped in all F2 mice. Although the distal
portion of the chromosome 2 as well as X chromo-
some were excluded from analysis, based on the 97
microsatellite markers used, approximate marker
density was 14.4^16.5 cM.
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Genomic DNA was prepared from the tails ac-
cording to the standard procedure. Microsatellite se-
quence length polymorphism was detected by electro-
phoresis subsequent to the polymerase chain
reaction. Most microsatellite primers were purchased
as MapPairs (Research Genetics, Hernstville, AL)
while others were synthesized. Ampli¢cation was car-
ried out using a Takara PCR thermal cycler MP
(Takara, Tokyo) under the following conditions:
1 cycle at 94‡C for 5 min; 35 cycles at 94‡C for
30 s, 55‡C for 1 min, and 72‡C for 45 s; 1 cycle at
72‡C for 7 min. All PCR products were electropho-
resed on 10% polyacrylamide gels (Pagel, Atto, Ja-
pan) for 70 min and visualized by ethidium bromide
staining.
2.4. Linkage analysis
For evaluation of phenotypes, F2 mice were
subdivided into two groups according to the geno-
type of the Ay allele at the agouti locus, that is, a/a
and Ay/a mice. Prior to statistical analysis, all phe-
notypic data were processed, standardized by sub-
tracting the mean and divided by standard deviation
for each sex to minimize gender di¡erences. Linkage
analysis was done with interval mapping using the
Mapmaker/QTL 1.1 b computer program [12,13].
QTL analysis was carried out on a/a mice and Ay/
a mice independently. Both groups of F2 mice were
partitioned according to genotype of closest marker
£anking to the putative QTL region. Two-way
ANOVA was applied to the raw data of each group
to assess the statistical signi¢cance of genotypes at
marker loci, gender and their interactions for all
traits. The chromosomal region with LOD score ex-
ceeding 4.3 (threshold of statistical signi¢cance at
the K= 0.05 level) was recognized as a signi¢cant
linkage and the region with LOD score of more
than 2.8, but less than 4.3, was taken as a suggestive
linkage [14]. The K-level for suggestive linkage im-
plies the expectation that there will be one false
positive in a genome-wide search.
Dominance of each QTL was demonstrated by
comparison of dominant, recessive and additive
models of the Mapmaker/QTL program, where
LOD score of 1.0 or greater di¡erence was used as
the criterion for determination.
2.5. Apolipoprotein A-II cDNA sequencing and
PCR-RFLP typing of apolipoprotein A-II gene
The open reading frame (ORF) of apolipoprotein
A-II cDNA sequences of C57BL/6J and KK strains
was determined by direct sequencing of RT-PCR
ampli¢ed fragments. cDNA from total mRNA
from the liver of KK and C57BL/6J female mice
was synthesized (Takara RNA PCR kit (AMV) Ver-
sion 2.1). ORF of apolipoprotein A-II sequence was
then ampli¢ed speci¢cally using the following set of
oligonucleotide primers of 5P-GCAGCACAGAAT-
CGCAGCACT-3P, and 5P-GAGAAAACAGGCA-
GAAGGTAGG-3P. The nucleotide sequence of 5P-
and 3P-untranslated region of apolipoprotein A-II
mRNA was determined by direct sequencing of
PCR ampli¢ed fragment using genomic DNA as
the template with the following sets of oligonucleo-
tide primers of 5P-AAGCTTGTGCCACTGTGCC-
TTGC-3P and 5P-TTGCGAGCAGCTTCATGATG-
GCA-3P for 5P-untranslated region, and 5PAAGA-
CACACGAGCAGCTGAC-3P and 5P-CCACCCT-
GCTACTTCTCCCA-3P for 3P-untranslated region.
PCR-RFLP typing of apolipoprotein A-II gene
was carried out as follows. Less than 200 bp PCR
fragment (ampli¢ed by the set of oligonucleotide
primers of 5P-TCTTCAGCAGTTTAATGAACCT-
3P and 5P-GCATTTATTGGAGAAAACAGGC-3P)
was ampli¢ed at the site from exon 3 to the 3P-un-
translated region based on the method by Ko et al.
[15]. The PCR product was diluted with TE bu¡er
four times and digested by XhoI restriction enzyme
(Toyobo, Tokyo, Japan). This enzyme could digest
the KK allele but could not the C57BL/6 allele, as
nucleotide di¡erences at the recognition site. Thus
following electrophoresis, the classi¢cation of apo-
lipoprotein A-II gene into any one of three classes,
that is homozygote for KK allele, heterozygote for
KK and C57BL/6 allele and homozygote for C57BL/
6 allele, was possible.
2.6. Statistical analysis
Statistical di¡erences in phenotypic values between
four F2 subgroups (a/a male, a/a female, Ay/a male,
Ay/a female) were examined by the Kruskal^Wallis
test in conjunction with Sche¡e¤’s F post-hoc test.
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3. Results
For all traits examined, no signi¢cant interactions
between gender and genotypes at marker loci could
be detected (ANOVA tables not shown). Subsequent
statistical analysis was thus conducted on males and
females independently by one-way ANOVA within
each genotype group at the agouti locus.
Triglyceride, HDL-cholesterol and NEFA plasma
values in parental C57BL/6J female (n = 10), KK-Ay
male (n = 10), KK male (n = 10), F1 (n = 7), and F2
are shown in Fig. 1. Phenotypic values for the F2
progeny are shown in Table 1. In triglyceride, total-
and HDL-cholesterol and phospholipid, di¡erences
in phenotypic values were not statistically signi¢cant
between F2 a/a males and females, or F2 Ay/a males
and females. However, the values for F2 a/a were
signi¢cantly lower than for F2 Ay/a. In NEFA, val-
ues for F2 Ay/a females were signi¢cantly higher than
for F2 a/a mice. Body weight signi¢cantly di¡ered
among four F2 subgroups (a/a male and female,
Ay/a male and female). Thus, the order of lipid levels
in the four F2 subgroups generally re£ected body
weight, and the Ay allele augmented lipid levels in
F2 mice (Table 1).
Loci including statistically signi¢cant and sugges-
tive linkages for various plasma lipids in F2 a/a and
F2 Ay/a progeny are indicated in Table 2. Each QTL
with statistically signi¢cant linkage was designated
by a gene symbol, such as Cq1 (Cholesterol QTL
no. 1), Cq2, Cq3, and Nq1 (NEFA QTL no. 1).
In the F2 a/a progeny, three loci for total-choles-
terol were noted on chromosome 1 (near D1Mit399
(LOD score 4.5) and near D1Mit150 (5.0), Fig. 2)
and chromosome 3 (near D3Mit102 (4.3)) with stat-
istical signi¢cance. For HDL-cholesterol, a locus
C
Fig. 1. Plots of plasma concentration of triglyceride (upper pan-
el), HDL-cholesterol (middle panel), and NEFA (lower panel)
from parental, F1 and F2 mice. Individual points on each graph
represents the plasma concentration of respective lipid class in a
mouse. Lanes: 1, KK-Ay males (n = 10); 2, KK males (n = 10);
3, C57BL/6J females (n = 10); 4, F1 a/a males (n = 7); 5, F1 a/a
females (n = 7); 6, F1 Ay/a males (n = 7); 7, F1 Ay/a females
(n = 7); 8, F2 a/a males (n = 49); 9, F2 a/a females (n = 44); 10,
F2 Ay/a males (n = 49); 11, F2 Ay/a females (n = 48). It is noted
that the lipid levels in KK-Ay are higher than in KK in gener-
al.
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with statistical signi¢cance was found on chromo-
some 1 (near D1Mit150 (4.5)) and two suggestively
linked loci were present on chromosomes 1 (near
D1Mit399 (3.9)) and 3 (near D3Mit102 (3.9)). For
triglyceride, a locus was identi¢ed on chromosome 9
near D9Mit163 (4.2), though without statistical sig-
ni¢cance (Fig. 3). For NEFA, a locus with signi¢cant
linkage was detected on chromosome 9 near
D9Mit353 (4.3) (Fig. 3). In F2 Ay/a mice, three loci
with suggestive linkages for total-cholesterol were
identi¢ed on chromosomes 1 (near D1Mit425 (4.0)
and near D1Mit150 (4.2) (Fig. 2) and 9 (near
D9Mit229 (3.3)). For HDL-cholesterol, two loci
with statistical signi¢cance were seen on chromosome
1 (near D1Mit425 (4.6), and near D1Mit150 (4.7))
and a locus with suggestive linkage was noted on
chromosome 9 (near D9Mit229 (3.0)). A suggestive
locus for NEFA and one for triglyceride were
mapped on chromosome 9, but the sites of the re-
spective loci di¡ered from those in F2 a/a.
An apolipoprotein A-II (Apoa2) locus is present
near D1Mit150 and possibly may determine the com-
position and plasma content of HDL. Nucleotide
sequences of apolipoprotein A-II cDNA from two
strains of KK and C57BL/6J were determined. Due
to seven nucleotide substitutions out of 309 nucleo-
Table 2
Identi¢cation of QTLs of plasma lipid
F2 mice Chromosome Closest marker LOD score (% variance)
Triglyceride Cholesterol NEFA Phospholipid Gene symbol
Total HDL
a/a 1 D1Mit399 4.5 (19.8) 3.9 (17.5) Cq1
a/a 1 D1Mit150 5.0 (22.1) 4.5 (20.0) Cq2
a/a 3 D3Mit102 4.3 (23.9) 3.9 (22.2) 3.6 (16.2) Cq3
a/a 9 D9Mit163 4.2 (18.7)
a/a 9 D9Mit353 4.3 (21.6) Nq1
a/a 12 D12Mit158 3.3 (15.0)
Ay/a 1 D1Mit425 4.0 (17.4) 4.6 (19.8) Cq1
Ay/a 1 D1Mit150 4.2 (18.2) 4.7 (20.0) Cq2
Ay/a 9 D9Mit196 2.8 (12.5) 2.9 (14.3)
Ay/a 9 D9Mit229 3.3 (15.1) 3.0 (14.4) 3.3 (14.3)
Ay/a 12 D12Mit190 3.4 (14.7)
Table 1
Phenotypic values for the F2 progeny
a/a male a/a female Ay/a male Ay/a female
Sample size n = 49 n = 44 n = 49 n = 48
Age (days) 195^198 206^207 184^186 191^192
Body weight (g) 45.0 þ 6.3a (32.4^60.5) 34.6 þ 6.5b (23.2^52.8) 50.9 þ 6.5c (36.7^64.2) 56.6 þ 6.7d (42.0^76.3)
Triglyceride
(mg/dl)
126.9 þ 47.1a (61^355) 112.1 þ 37.8a (43^250) 158.1 þ 53.6b (71^282) 175.1 þ 62.3b (90^415)
Total-cholesterol
(mg/dl)
105.6 þ 34.0a (60^230) 87.6 þ 20.4a (54^149) 132.1 þ 38.4b (83^233) 149.0 þ 55.5b (61^347)
HDL-cholesterol
(mg/dl)
87.0 þ 24.1a (53^163) 71.9 þ 16.6a (45^118) 103.3 þ 27.9b (60^180) 110.4 þ 32.8b (46^195)
NEFA (mg/dl) 54.1 þ 13.5a (25.4^103.1) 57.2 þ 13.0a (22.3^87.6) 62.2 þ 16.6a;b (32.8^97.2) 68.0 þ 13.8b (41.5^110.5)
Phospholipid
(mg/dl)
189.6 þ 51.5a (121^357) 163.0 þ 32.7a (92^263) 237.0 þ 65.5b (149^425) 265.8 þ 80.9b (120^540)
Data expressed as means þ S.D. (range: minimum^maximum value).
Values with di¡erent superscripts are signi¢cantly di¡erent (P6 0.05).
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tide open reading frame, three amino acid di¡erences
were found for the two strains (Fig. 4). In contrast,
there were no di¡erences in the 5P- and 3P-untrans-
lated sequences. The locus on chromosome 9 for
NEFA and triglyceride in F2 a/a mice was mapped
near that of hepatic lipase (Lipc), although cDNA
sequences of the two strains were essentially the
same (data not shown).
Subsequent to apolipoprotein A-II PCR-RFLP
analysis based on sequence di¡erences spanning
from the last exon to the 3P-untranslated region
[15], we mapped the Apoa2 locus and con¢rmed the
Fig. 2. Identi¢cation of QTLs for HDL-cholesterol on chromosome 1. (a) F2 a/a progeny. (b) F2 Ay/a progeny. Constrained genetic
models by Mapmaker/QTL program are presented. Horizontal dotted line indicates LOD score of 4.3, the threshold being statistically
signi¢cant. Figures between markers indicate distances (cM) between markers as determined by the Mapmaker program.
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Apoa2 to be located very near D1Mit150 (distance
between Apoa2 and D1Mit150 was 1.1 cM in F2 a/a,
and 0.5 cM in F2 Ay/a (Fig. 2)). For HDL-cholester-
ol, the results of one-way ANOVA are shown in
Table 3. Di¡erences in females were particularly sig-
ni¢cant. In the F2 a/a cohort, loci on chromosome
3 for total- and HDL-cholesterol behaved in oppo-
site manner and homozygotes for the C57BL/6J
allele at either locus exhibited increased values.
For total-cholesterol: KK/KK, 92.5 þ 22.5; KK/B6,
Table 3
Results of ANOVA for HDL cholesterol
Marker or lo-
cus
Cross and gender Cholesterol concentration (mg/dl) by marker genotypea P-value Dominance
KK/KK KK/B6 B6/B6
D1Mit399 a/a male 95.8 þ 24.1 (12)b 87.5 þ 24.4 (26) 76.0 þ 20.8 (11) 0.14 Dominant or additive
D1Mit399 a/a female 87.7 þ 14.1 (7) 74.6 þ 16.0 (22) 60.4 þ 10.0 (15) 0.0002 Dominant or additive
D1Mit150 a/a male 93.1 þ 28.6 (18) 89.4 þ 20.3 (22) 69.7 þ 14.0 (9) 0.03 Dominant
D1Mit150 a/a female 80.6 þ 21.4 (7) 77.5 þ 14.4 (22) 59.6 þ 9.6 (15) 0.0008 Dominant
Apoa2 a/a male 93.4 þ 29.4 (17) 88.8 þ 20.1 (22) 72.0 þ 16.9 (10) 0.07 Dominant
Apoa2 a/a female 80.6 þ 21.4 (7) 77.5 þ 14.4 (22) 59.6 þ 9.6 (15) 0.0008 Dominant
D1Mit425 Ay/a male 119.5 þ 30.2 (11) 102.0 þ 27.8 (28) 89.1 þ 16.7 (10) 0.03 Additive
D1Mit425 Ay/a female 128.9 þ 36.5 (14) 113.7 þ 27.1 (22) 82.6 þ 17.7 (12) 0.0005 Additive
D1Mit150 Ay/a male 112.0 þ 30.5 (13) 105.6 þ 28.2 (25) 87.8 þ 18.7 (11) 0.087 Dominant or additive
D1Mit150 Ay/a female 131.2 þ 37.4 (14) 112.7 þ 24.9 (23) 79.0 þ 13.3 (11) 0.00009 Dominant or additive
Apoa2 Ay/a male 112.0 þ 30.5 (13) 104.2 þ 28.5 (26) 89.7 þ 18.6 (10) 0.16 Dominant or additive
Apoa2 Ay/a female 131.2 þ 37.4 (14) 112.7 þ 24.9 (23) 79.0 þ 13.3 (11) 0.00009 Dominant or additive
aAll data expressed as mean þ S.D.
bNo. of mice indicated in parentheses.
Fig. 3. Identi¢cation of QTL for triglyceride and NEFA in F2 a/a mice, expressed as the free genetic model obtained with the Map-
maker/QTL program. Figures between markers indicate distances (cM) between markers as determined with the Mapmaker program.
BBADIS 61821 24-3-99
J. Suto et al. / Biochimica et Biophysica Acta 1453 (1999) 385^395 391
BBADIS 61821 24-3-99
J. Suto et al. / Biochimica et Biophysica Acta 1453 (1999) 385^395392
100.7 þ 24.9; B6/B6, 136.3 þ 48.9 (mean þ S.D.) in
males (P = 0.0029); and KK/KK, 82.8 þ 17.5; KK/
B6, 83.8 þ 11.9; B6/B6., 102.2 þ 29.6 (mean þ S.D.)
in females (P = 0.031). For HDL-cholesterol: KK/
KK, 78.4 þ 17.7; KK/B6, 83.7 þ 19.4; B6/B6,
107.0 þ 32.6 (mean þ S.D.) in males (P = 0.0078);
and KK/KK, 66.9 þ 16.0; KK/B6, 70.0 þ 9.6; B6/
B6, 83.5 þ 22.2 (mean þ S.D.) in females (P = 0.031).
4. Discussion
KK mice develop NIDDM and moderate obesity
[4]. For greater clari¢cation of diabetic pathogenesis
in KK, the Ay allele was previously introduced onto
the KK background [6]. The ectopically expressed
agouti peptide (yellow gene product) has been shown
to antagonize the K-melanocyte-stimulating hormone
at the melanocortin 4 receptor, thereby causing en-
hanced obesity [16^19]. In C57BL/6-Ay mice, obesity
is essentially the same as in KK-Ay with hyperglyce-
mic tendency, but glucose tolerance is less a¡ected
than in KK-Ay. Plasma lipid in KK is higher than
in C57BL/6J mice (Clea, Japan). The in£uence of Ay
allele on plasma lipid has been studied in C57BL/6
background [20], but its e¡ects were not so intense as
on body weight. In the KK background, this Ay
allele appears to enhance hyperlipidemia and thus
exerts strong genetic e¡ect.
A number of genomic intervals and candidate loci
related to lipid metabolism, especially cholesterol ho-
meostasis, have been mapped and the relation to
obesity has been described [21,22]. Mapping in other
combination of mouse strains should provide addi-
tional clari¢cation of pathophysiological features of
altered lipid metabolism. To determine the gene or
genes responsible for lipid metabolism in KK mouse
chromosomes, linkage mapping was conducted.
Irrespective of genotype at the agouti locus in F2
mice, QTL for cholesterol was mapped on chromo-
some 1, near D1Mit150, in the vicinity of the apo-
lipoprotein A-II locus. PCR-RFLP typing of apo-
lipoprotein A-II surely con¢rmed the existence of
HDL-cholesterol QTL on this locus.
According to Purcell-Huynh et al. [8], plasma apo-
lipoprotein A-II protein and HDL-cholesterol levels
are segregated with the apolipoprotein A-II gene in a
mapping population obtained from a cross between
NZB female and SM male. They suggest that genetic
variation of the apolipoprotein A-II gene determines
plasma apolipoprotein A-II levels (at the level of
catabolism rather than synthesis) which then in
turn in£uence HDL-cholesterol levels. Thus, apolipo-
protein A-II is a major constituent lipoprotein in
HDLs and structural polymorphism in the apolipo-
protein A-II gene should determine HDL particle
size and plasma HDL-cholesterol, seemingly by
post-translational modi¢cation [23]. Machleder et
al. [24] found HDL-cholesterol levels to be also seg-
regated with the apolipoprotein A-II gene in a map-
ping population of the F2 intercross progeny pro-
duced from a cross between C57BL/6J female and
C3H/HeJ male and they suggest HDL-cholesterol
QTL to be due to variation in the expression of
apolipoprotein A-II. This explanation appears sup-
ported by results for transgenic mice [25]. Transgenic
mice which overexpress mouse apolipoprotein A-II
had higher HDL-cholesterol levels than non-trans-
genic mice and the HDL particle was large.
Although we did not determine plasma apolipo-
protein A-II protein levels nor expression of the apo-
lipoprotein A-II gene, there is non-conclusive proof
of marked di¡erence in plasma HDL-cholesterol lev-
els for KK and C57BL/6J. The apolipoprotein A-II
amino acid sequence indicated KK mouse sequence
to be completely the same as that of BALB/c, C3H/
HeJ and NZB. The plasma apolipoprotein A-II pro-
tein (not determined in KK) and HDL-cholesterol
levels of these strains have been shown higher than
for other strains in respective crosses [8,24]. The apo-
Fig. 4. Comparison of apolipoprotein A-II cDNA and amino acid sequences for KK and C57BL/6J. Seven nucleotide substitutions
out of 309 with consequent three amino acid di¡erences were noted for the two strains. (A) Comparison of nucleotide sequence of
apolipoprotein A-II cDNA. The primer sequences used for apolipoprotein A-II PCR-RFLP analysis is double-underlined and the
XhoI recognition site is surrounded by an open box. (B) Deduced amino acid sequences. Notably, the KK sequence is completely the
same as that of C3H/HeJ and NZB ([23] and [24], respectively).
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lipoprotein A-II in KK may thus possibly exceed
C57BL/6J, with consequently higher HDL-cholester-
ol levels in KK. Thus, plasma HDL-cholesterol in
KK is mainly regulated by apolipoprotein A-II poly-
morphism and accordingly genetic loci for HDL-cho-
lesterol do not coincide with those for body weight
and obesity.
In addition to close linkages between QTL located
near D1Mit150 and apolipoprotein A-II, several can-
didate genes could be postulated for other QTLs. On
chromosome 1 where distinct QTL is situated more
proximally between D1Mit425 and D1Mit399, there
is the acyl-CoA: cholesterol acyltransferase (Acact)
locus as a candidate gene. ACAT is an enzyme that
catalyzes the esteri¢cation of cholesterol, conse-
quently altering cellular and peripheral cholesterol
levels [26].
The in£uence of chromosome 9 on various plasma
lipids is demonstrated by the present study. In the F2
a/a progeny, loci for NEFA and triglyceride were
mapped on identical regions on chromosome 9. In
a neighboring region, a hepatic lipase (Lipc) locus
was found to be present. No alteration in hepatic
lipase cDNA sequences for KK and C57BL/6J could
be detected (data not shown). There may possibly be
additional loci for NEFA and triglyceride, since the
variance attributed to each locus is relatively little.
Several apolipoprotein loci, including Apoa1,
Apoa4 and Apoc3, are located on chromosome 9,
suggesting phenotypic di¡erences between the strains
to possibly be due to these genes. Particularly in the
case of F2 Ay/a mice cholesterol, the D9Mit229
marker indicated evidence of suggestive linkages
with total- and HDL-cholesterol. The D9Mit229 lo-
cus had no or only slight in£uence on cholesterol in
F2 a/a mice, and thus may be considered to interact
with the Ay allele.
Based on the present results, the following conclu-
sions may be drawn: (1) through identi¢cation of
QTLs, a polygenic basis for plasma lipid concentra-
tions in KK was established; (2) although the e¡ects
of body weight on lipid concentration cannot be
ruled out, genetic loci for lipid regulation clearly dif-
fered from those responsible for obesity; and (3) the
e¡ects of Ay allele on quantitative regulation of plas-
ma lipids appear slight in contrast to weight con-
trol.
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